Pacific Edge Limited (PFGTF) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pacific Edge Limited reports a steady performance for the six months ending in September 2024, despite challenges posed by Medicare uncertainties. The company’s operating revenue increased slightly, with promising developments in securing Medicare coverage for its Cxbladder tests and advancing new product launches. With a strong cash reserve, Pacific Edge remains focused on maintaining profitability and expanding its market presence.
For further insights into PFGTF stock, check out TipRanks’ Stock Analysis page.